American Herbal Products Association (AHPA) > News > Latest News

NIH Office of Dietary Supplements seeks comments on Dietary Supplement Label Database

Color additive regulations expand the permitted use of spirulina extract (Federal Register)

Editor's Note: The FDA has confirmed the effective date as September 22, 2015, for the Final Rule that amended the color additive regulations to expand the permitted use of spirulina extract as a color additive to include use in coating formulations applied to dietary supplement and drug tablets and capsules. FDA received no objections or requests for a hearing on the final rule. 

AHPA joins coalition opposing proposed revision to Prop 65 lead safe harbor

October 2015: OEHHA proposal is problematic from both a policy and scientific standpoint

AHPA joined a coalition to express concerns about OEHHA's proposed revisions to the Proposition 65 safe harbor Maximum Allowable Dose Levels (MADLs) for lead

GNC issues response to Oregon AG lawsuit (GNC)

Editor's Note: GNC issued the statement below noting that the lawsuit filed by the Oregon Attorney General is "without merit" and that the company will "defend itself vigorously against this unfair action."

Major victory for California marijuana dispensary in federal court

Editor's Note: A federal judge in California ruled on Oct. 19 that Congressional law defunding the Justice Department's war on medical marijuana means what it was intended to mean, that the war on medical cannabis is over. Judge Breyer ruled, "the plain reading of [Congressional law] forbids the Department of Justice from enforcing this injunction against [Marin Alliance for Medical Marijuana (MAMM)] to the extent that MAMM operates in compliance with state California law." The medical cannabis industry in California and beyond has faced a federal crackdown since 2011, with dispensaries such as Harborside Health Center and Berkeley Patients Group both facing federal forfeiture actions. The judge's order lifting an injunction against the MAMM may have far reaching legal impact for the industry, according to attorneys.

AHPA Provides Perspective on Emergency Room Visits Purportedly Associated with Supplements

When placed into context, study demonstrates relative safety of supplements

Article published in New England Journal of Medicine

overstates emergency room (ER) visits associated with dietary supplements. Study also shows supplements are relatively safe compared to other product categories.

Minimizing confusion when products fail in the October 2015 AHPA Report

Log in to access this AHPA Report

AHPA provides regulatory insight on essential oils at aromatherapy conference

American Herbal Products Association (AHPA) Special Regulatory Counsel Tami Wahl provided an overview of federal regulatory compliance issues pertaining to essential oils during the Alliance of International Aromatherapists' (AIA) 2015 International Aromatherapy Conference and Wellness Expo last week in Denver.

FDA issues final FSMA preventive controls regulations for human and animal food

September 2015: AHPA Update

The Food and Drug Administration (FDA) last week released two final Food Safety Modernization Act (FSMA) regulations with sweeping new requirements for manufacturers of human food and animal feed.

Physician provides data on Americans' alarming nutrient deficiencies at Congressional Dietary Supplement Caucus briefing

CDC data show that Americans don't get sufficient essential nutrients from food alone

Washington, D.C., Sept. 11, 2015 -- Data from the Centers on Disease Control and Prevention (CDC) show that tens of millions of Americans aren't getting enough essential nutrients to ensure their bodies function optimally, a stark contrast to headlines and soundbites that assert Americans get the nutrients they need from food alone.
RSS
First 41424344454647484950 Last

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.